Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |